Bucelon 2mg Tablet

The doctor determines the dosage of Bucelon 2mg Tablet as per the patient's health and other medical conditions. Take this medicine at the same time every day as prescribed by your doctor for effective results. It can be taken orally, with or without food. In case of an overdose, contact your doctor immediately.

Bucelon 2mg Tablet is an anticancer medicine used to treat certain blood disorders & cancers. This medicine works by damaging & interfering with the genetic material (DNA/ RNA) of blood cancer cells, which results in the inhibition of growth & multiplication of cancer cells.

It is advised not to miss any scheduled dosage of Bucelon 2mg Tablet. In case you miss a dose, consult your doctor immediately.
Don't overdose to compensate for the missed one. Contact your doctor or any healthcare provider and seek medical attention immediately in such cases.

It is advised to use effective birth control ways and avoid pregnancy during the treatment with Bucelon 2mg Tablet.

It is advised to avoid taking analgesics/ antacids (medicines used to neutralize the stomach acid) while taking Bucelon Tablet, as it may reduce the effectiveness of the medicine.

Keep your body hydrated as Diarrhea is one of the common side effects experienced after taking Bucelon Tablet. Consult your doctor if it doesn't stop or if blood appears in your stools.

In case you notice symptoms like blurred vision, difficulty breathing, cough & fever, and diarrhea while taking Bucelon 2mg Tablet, consult your doctor immediately before these symptoms become severe.

If you experience any kind of symptoms after taking Bucelon 2mg Tablet like unexplained bruising or bleeding, sore throat, mouth ulcers, high temperature (fever), or other signs of infection, it is important to Inform your doctor as soon as possible.

At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.

Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.

Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.


We currently ship to:

Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!

1. Galton, D. A. G. (1958). Busulphan Therapy. British Medical Journal, 1(5064), 216.
2. Shaw, P. J., Nath, C., Berry, A., & Earl, J. W. (2004). Busulphan given as four single daily doses of 150 mg/m2 is safe and effective in children of all ages. Bone marrow transplantation, 34(3), 197-205.
3. Stott, H., Stephens, R., Fox, W., Simon, G., & Roy, D. C. (1976). An investigation of the chest radiographs in a controlled trial of busulphan, cyclophosphamide, and a placebo after resection for carcinoma of the lung. Thorax, 31(3), 265-270.
4. Hassan, M., Öberg, G., Bekassy, A. N., Aschan, J., Ehrsson, H., Ljungman, P., ... & Simonsson, B. (1991). Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology. Cancer chemotherapy and pharmacology, 28(2), 130-134.
5. Ellen Nath, C., & John Shaw, P. (2007). Busulphan in blood and marrow transplantation: dose, route, frequency and role of therapeutic drug monitoring. Current clinical pharmacology, 2(1), 75-91.